Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2457.0000 32.30 (1.33%)
NSE Sep 30, 2025 10:35 AM
Volume: 11,788
 

logo
Ajanta Pharma Ltd.
16 May 2018
2457.00
1.33%
buy
Results Update: Ajanta Pharma Ltd.
by HDFC Securities
HDFC Securities
Revenue fell by 9.67% to Rs. 530.31 Cr in Q4FY18 when compared to the previous quarter. Ajanta Pharma Ltd Q4FY18 Results Comment
 
Prabhudas Lilladhar released a Buy report for Ajanta Pharma Ltd. with a price target of 3200.0 on 19 Sep, 2025.
More from Ajanta Pharma Ltd.
Recommended
Market trades flat, SEBI bans Man Ind and three senior executives from trading securities
Trendlyne Marketwatch | 30 Sep 2025, 10:22AM
IPO frenzy continues: 23 companies to list; 21 new issues hit the market this week
| 29 Sep 2025, 04:41PM
Ajanta Pharma disputes ET article on FDA import alert
| 24 Jan 2017